U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07078331) titled 'Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations' on July 09.

Brief Summary: This study's objective is to evaluate OsteoAdapt DE's safety and performance in comparison to Xenograft particulate bone graft for alveolar ridge augmentation. Additionally, the study aims to optimize OsteoAdapt DE dosing for future studies by assessing two concentrations: a low dose (0.8 mg/cc) and a high dose (2.0 mg/cc).

Study Start Date: July 17

Study Type: INTERVENTIONAL

Condition: Tooth Extraction Site Healing Ridge Augmentation Bone Graft

Intervention: DEVICE: OsteoAdapt DE (0.8 mg)

Procedure of sing...